ExcepGen
PrivateLast Round
Seed
Aug 24, 2023
Est. Valuation
$2.14M
Total Funding Raised
$4.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ExcepGen is a biotechnology company that is developing a platform for nucleic acid therapeutics designed to improve the efficacy and tolerability of DNA and RNA-based medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExcepGen Comparables
Compare ExcepGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Replicate Bioscience | 78% | |
| Kernalbio | 77% | |
| eTheRNA | 76% |
ExcepGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 24, 2023 | ||||
| Accelerator | Mar 15, 2019 |
ExcepGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| ZAKA VC | Seed |
| VitaDAO | Accelerator |
| Gravity Fund | Seed |
| Y Combinator | Accelerator |
| Gravity Fund | Seed |
| Apollo Projects | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 286% MoM, from 329 to 1.3K.
- Aug 24, 2023
$4M round led by RA Capital Management
ExcepGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ExcepGen's valuation, stock price, and market status.
Is ExcepGen a public or private company?
ExcepGen is a private company.
What is the current stock price of ExcepGen?
ExcepGen is a private company with no public stock price. No recent secondary market data is available.
How much is ExcepGen worth (valuation)?
Valuation information for ExcepGen is not publicly available.
Can I buy ExcepGen stock?
ExcepGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ExcepGen's last funding round?
ExcepGen's most recent funding round was Seed on August 24, 2023.
Who are the main investors in ExcepGen?
Key investors in ExcepGen include RA Capital Management.
Will ExcepGen IPO soon?
No public IPO plans have been announced for ExcepGen.
How can I track ExcepGen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ExcepGen's secondary market activity and sign up for updates.